Cargando…

Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue

Fluorescence microscopy is widely used for high content screening in 2D cell cultures and 3D models. In particular, 3D tissue models are gaining major relevance in modern drug development. Enabling direct multiparametric evaluation of complex samples, fluorescence lifetime imaging (FLIM) adds a furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodwolf, Robert, Volz-Rakebrand, Pierre, Stellmacher, Johannes, Wolff, Christopher, Unbehauen, Michael, Haag, Rainer, Schäfer-Korting, Monika, Zoschke, Christian, Alexiev, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255044/
https://www.ncbi.nlm.nih.gov/pubmed/32483455
http://dx.doi.org/10.7150/thno.42581
_version_ 1783539656990654464
author Brodwolf, Robert
Volz-Rakebrand, Pierre
Stellmacher, Johannes
Wolff, Christopher
Unbehauen, Michael
Haag, Rainer
Schäfer-Korting, Monika
Zoschke, Christian
Alexiev, Ulrike
author_facet Brodwolf, Robert
Volz-Rakebrand, Pierre
Stellmacher, Johannes
Wolff, Christopher
Unbehauen, Michael
Haag, Rainer
Schäfer-Korting, Monika
Zoschke, Christian
Alexiev, Ulrike
author_sort Brodwolf, Robert
collection PubMed
description Fluorescence microscopy is widely used for high content screening in 2D cell cultures and 3D models. In particular, 3D tissue models are gaining major relevance in modern drug development. Enabling direct multiparametric evaluation of complex samples, fluorescence lifetime imaging (FLIM) adds a further level to intensity imaging by the sensitivity of the fluorescence lifetime to the microenvironment. However, the use of FLIM is limited amongst others by the acquisition of sufficient photon numbers without phototoxic effects in live cells. Herein, we developed a new cluster-based analysis method to enhance insight, and significantly speed up analysis and measurement time for the accurate translation of fluorescence lifetime information into pharmacological pathways. Methods: We applied a fluorescently-labeled dendritic core-multishell nanocarrier and its cargo Bodipy as molecules of interest (MOI) to human cells and reconstructed human tissue. Following the sensitivity and specificity assessment of the fitting-free Cluster-FLIM analysis of data in silico and in vitro, we evaluated the dynamics of cellular molecule uptake and intracellular interactions. For 3D live tissue investigations, we applied multiphoton (mp) FLIM. Owing to Cluster-FLIM's statistics-based fitting-free analysis, we utilized this approach for automatization. Results: To discriminate the fluorescence lifetime signatures of 5 different fluorescence species in a single color channel, the Cluster-FLIM method requires only 170, respectively, 90 counts per pixel to obtain 95% sensitivity (hit rate) and 95% specificity (correct rejection rate). Cluster-FLIM revealed cellular interactions of MOIs, representing their spatiotemporal intracellular fate. In a setting of an automated workflow, the assessment of lysosomal trapping of the MOI revealed relevant differences between normal and tumor cells, as well as between 2D and 3D models. Conclusion: The automated Cluster-FLIM tool is fitting-free, providing images with enhanced information, contrast, and spatial resolution at short exposure times and low fluorophore concentrations. Thereby, Cluster-FLIM increases the applicability of FLIM in high content analysis of target molecules in drug development and beyond.
format Online
Article
Text
id pubmed-7255044
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-72550442020-05-31 Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue Brodwolf, Robert Volz-Rakebrand, Pierre Stellmacher, Johannes Wolff, Christopher Unbehauen, Michael Haag, Rainer Schäfer-Korting, Monika Zoschke, Christian Alexiev, Ulrike Theranostics Research Paper Fluorescence microscopy is widely used for high content screening in 2D cell cultures and 3D models. In particular, 3D tissue models are gaining major relevance in modern drug development. Enabling direct multiparametric evaluation of complex samples, fluorescence lifetime imaging (FLIM) adds a further level to intensity imaging by the sensitivity of the fluorescence lifetime to the microenvironment. However, the use of FLIM is limited amongst others by the acquisition of sufficient photon numbers without phototoxic effects in live cells. Herein, we developed a new cluster-based analysis method to enhance insight, and significantly speed up analysis and measurement time for the accurate translation of fluorescence lifetime information into pharmacological pathways. Methods: We applied a fluorescently-labeled dendritic core-multishell nanocarrier and its cargo Bodipy as molecules of interest (MOI) to human cells and reconstructed human tissue. Following the sensitivity and specificity assessment of the fitting-free Cluster-FLIM analysis of data in silico and in vitro, we evaluated the dynamics of cellular molecule uptake and intracellular interactions. For 3D live tissue investigations, we applied multiphoton (mp) FLIM. Owing to Cluster-FLIM's statistics-based fitting-free analysis, we utilized this approach for automatization. Results: To discriminate the fluorescence lifetime signatures of 5 different fluorescence species in a single color channel, the Cluster-FLIM method requires only 170, respectively, 90 counts per pixel to obtain 95% sensitivity (hit rate) and 95% specificity (correct rejection rate). Cluster-FLIM revealed cellular interactions of MOIs, representing their spatiotemporal intracellular fate. In a setting of an automated workflow, the assessment of lysosomal trapping of the MOI revealed relevant differences between normal and tumor cells, as well as between 2D and 3D models. Conclusion: The automated Cluster-FLIM tool is fitting-free, providing images with enhanced information, contrast, and spatial resolution at short exposure times and low fluorophore concentrations. Thereby, Cluster-FLIM increases the applicability of FLIM in high content analysis of target molecules in drug development and beyond. Ivyspring International Publisher 2020-05-15 /pmc/articles/PMC7255044/ /pubmed/32483455 http://dx.doi.org/10.7150/thno.42581 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Brodwolf, Robert
Volz-Rakebrand, Pierre
Stellmacher, Johannes
Wolff, Christopher
Unbehauen, Michael
Haag, Rainer
Schäfer-Korting, Monika
Zoschke, Christian
Alexiev, Ulrike
Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
title Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
title_full Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
title_fullStr Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
title_full_unstemmed Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
title_short Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
title_sort faster, sharper, more precise: automated cluster-flim in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255044/
https://www.ncbi.nlm.nih.gov/pubmed/32483455
http://dx.doi.org/10.7150/thno.42581
work_keys_str_mv AT brodwolfrobert fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT volzrakebrandpierre fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT stellmacherjohannes fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT wolffchristopher fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT unbehauenmichael fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT haagrainer fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT schaferkortingmonika fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT zoschkechristian fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue
AT alexievulrike fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue